Stock market indexes are jumping massive amounts in premarket trading in reaction to last night's election.
Jay Woods, Freedom Capital Markets chief global strategist, joins 'Power Lunch' to discuss stock plays for three stocks.
It has been a rotten year for Apellis Pharmaceuticals stock, but better times could be ahead.
Tech stocks like GOOGL, AVGO, NFLX and PANW are poised to benefit from the ongoing Nasdaq rally.
The CNN Money Fear and Greed index showed a decline in the overall market sentiment, while the index remained in the “Greed” zone on Friday.
NDAQ's third-quarter results reflect broad-based growth across three divisions and another quarter of double-digit Solutions growth.
Although the revenue and EPS for Nasdaq (NDAQ) give a sense of how its business performed in the quarter ended September 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Nasdaq (NDAQ) came out with quarterly earnings of $0.74 per share, beating the Zacks Consensus Estimate of $0.69 per share. This compares to earnings of $0.71 per share a year ago.
The company is performing well despite recently losing its biggest growth driver.
Beyond analysts' top -and-bottom-line estimates for Nasdaq (NDAQ), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended September 2024.
Nebius, the company formerly known as Yandex that's now focused on cloud infrastructure for AI uses (aka “AI compute”), is to begin trading on the public markets once again — more than two years after the Nasdaq halted trading due to economic sanctions imposed in the wake of Russia's Ukraine invasion in 2022.
Nasdaq has introduced technology to calculate investment portfolio risk using machine learning. The new functionality, announced Thursday (Oct. 17), will be woven into Nasdaq's Calypso platform, used by banks, insurers and other financial institutions to do things like access capital markets, manage risk and adhere to regulatory reporting obligations.